Plain-English translation of NCT07758634 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Hypertension research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is one of the first times this treatment has been tested in people.
This trial is testing a new approach to treating high blood pressure that doesn't respond well to standard medications. is an experimental treatment that uses gene-editing technology to modify how your body produces a substance that affects blood pressure. Researchers will give some participants the medication and others a placebo (inactive treatment) through an IV infusion to see if it's safe and whether it helps lower blood pressure.
Many people with high blood pressure struggle to control it even while taking four or more different medications. This medication represents a completely new approach—instead of managing symptoms with daily pills, it aims to address a root cause by editing the genes responsible for blood pressure regulation.
You likely qualify if…
You likely don't qualify if…
In Phase 1, participants will receive increasing doses of the medication or placebo via IV infusion to test safety. In Phase 2, a larger group will receive either the recommended dose from Phase 1 or a placebo. You'll have regular blood pressure monitoring, blood tests, and follow-up visits to track how the treatment affects you and watch for any side effects. The trial will involve multiple visits over several months to carefully evaluate whether this new approach is safe and effective.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
United States
Australia